The US National Institutes of Health (NIH) together with Fitbit have launched the Bring Your Own Device project, enabling Fitbit users to share data with the NIH ‘All of Us’ programme.
Venture capital funding for digital health companies grew to $9.5 billion in 2018, up 32% from $7.2 billion in 2017, according to Mercom Capital Group, a global communications and research firm.
Roche has today launched its uPath digital pathology software. It enables pathologists to diagnose a patient case more quickly by viewing all slides in a case in a single seamless view, as well as viewing all available patient information simultaneously. The software is built on the Leeds Virtual Microscope (LVM) developed at – and acquired from […]
Medical researchers in Britain and Japan are to join forces in the fight to advance research into treatments for some of the most debilitating degenerative diseases.
WeHealth by Servier and Pathmaker Neurosystems have formed a partnership to develop and commercialise Pathmaker’s MyoRegulator device, a non-invasive treatment for spasticity.
JPND, the EU’s neurodegenerative disease research initiative, has announced a €30 million call for multinational research on personalised medicine for neurodegenerative diseases.
The Consumer Electronics Show (CES) 2019 kicks off in Las Vegas today, and will feature some advances in healthtech wearables. Amongst these are a collaboration between Garmin and Daimler, and a new product launch from Flint Rehab. Garmin is teaming up with Daimler to enhance the Mercedes Benz driver experience. Daimler will introduce a Mercedes-Benz branded […]
The UK’s NHS has today published its Long Term Plan, which sets out a vision to save half a million lives ‘with practical action on major killer conditions and investment in world class, cutting edge treatments’ over the next decade. At the heart of the plans is the use of technology for a wide range […]
The Bill and Melinda Gates Foundation and WuXi AppTec’s Corporate Venture Fund have led an $85 million funding round into Schrödinger. The company produces a computational platform for drug discovery, which it also uses for its own research.
Research carried out during the 2018 Lassa fever outbreak in Nigeria used rapid, portable genomic sequencing technology to identify viruses without prior knowledge of the cause of disease. This enabled researchers to allay fears and direct the public health interventions to limit the spread of the virus and help to protect more people from disease.